When facing major transformation there are various approaches available. In this case study Arne Buthmann and Amy Pott explore a joint approach used in Shire.
"The key to get to speed and rapid iteration is to work more iteratively." For more insights listen to Thomas and Arne's key takeaways on developments and opportunities in the pharmaceutical industry.
[Case Study] A New Commercial Model: Improving Patient Access through Integrated Personal and Non-Personal Promotion
Building global MCM capabilities that can be leveraged across all markets promises significant economies of scale. So let's take a look at what the local differences are that need be considered and the challenges of deploying MCM globally, and how biopharma companies can set themselves up for success.
"The ability to make your solution scalable on a global level depends on your ability to target the right markets with the right solutions." - Jerry Julian | Director, Global Program Management - Multi-channel Marketing, Sanofi